Zhejiang Jingxin Pharmaceutical Co Ltd (002020) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.040x

Based on the latest financial reports, Zhejiang Jingxin Pharmaceutical Co Ltd (002020) has a cash flow conversion efficiency ratio of 0.040x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥227.64 Million ≈ $33.31 Million USD) by net assets (CN¥5.69 Billion ≈ $831.97 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Zhejiang Jingxin Pharmaceutical Co Ltd (002020) liquidity interval to measure how many days the company can operate on defensive assets alone.

Zhejiang Jingxin Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2002–2025)

This chart illustrates how Zhejiang Jingxin Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Zhejiang Jingxin Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zhejiang Jingxin Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Dynamic Holding Co. Ltd.
TW:3715
-0.034x
Expro Group Holdings NV
NYSE:XPRO
0.017x
Parade Technologies Ltd
TWO:4966
0.039x
Five-Star Business Finance Limited
NSE:FIVESTAR
0.002x
Argan SA
PA:ARG
0.037x
Central Plaza Hotel Public Company Limited
BK:CENTEL
0.071x
LANXESS Aktiengesellschaft
F:LXS
0.013x
Israel Canada
TA:ISCN
-0.076x

Annual Cash Flow Conversion Efficiency for Zhejiang Jingxin Pharmaceutical Co Ltd (2002–2025)

The table below shows the annual cash flow conversion efficiency of Zhejiang Jingxin Pharmaceutical Co Ltd from 2002 to 2025. For the full company profile with market capitalisation and key ratios, see 002020 market cap.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥5.87 Billion
≈ $859.00 Million
CN¥781.35 Million
≈ $114.34 Million
0.133x +10.01%
2024-12-31 CN¥6.00 Billion
≈ $878.21 Million
CN¥726.16 Million
≈ $106.26 Million
0.121x -18.72%
2023-12-31 CN¥5.54 Billion
≈ $810.70 Million
CN¥824.69 Million
≈ $120.68 Million
0.149x -10.04%
2022-12-31 CN¥5.17 Billion
≈ $756.82 Million
CN¥855.78 Million
≈ $125.23 Million
0.165x +119.29%
2021-12-31 CN¥4.84 Billion
≈ $707.90 Million
CN¥365.02 Million
≈ $53.41 Million
0.075x -42.18%
2020-12-31 CN¥3.93 Billion
≈ $575.47 Million
CN¥513.21 Million
≈ $75.10 Million
0.130x -9.54%
2019-12-31 CN¥3.71 Billion
≈ $542.99 Million
CN¥535.30 Million
≈ $78.33 Million
0.144x -1.51%
2018-12-31 CN¥3.57 Billion
≈ $522.90 Million
CN¥523.40 Million
≈ $76.59 Million
0.146x +50.87%
2017-12-31 CN¥3.97 Billion
≈ $580.29 Million
CN¥385.01 Million
≈ $56.34 Million
0.097x -6.78%
2016-12-31 CN¥2.43 Billion
≈ $355.06 Million
CN¥252.69 Million
≈ $36.98 Million
0.104x +62.70%
2015-12-31 CN¥2.26 Billion
≈ $330.78 Million
CN¥144.69 Million
≈ $21.17 Million
0.064x -57.47%
2014-12-31 CN¥1.40 Billion
≈ $204.65 Million
CN¥210.49 Million
≈ $30.80 Million
0.151x +10.88%
2013-12-31 CN¥817.98 Million
≈ $119.70 Million
CN¥111.03 Million
≈ $16.25 Million
0.136x +73.98%
2012-12-31 CN¥772.58 Million
≈ $113.05 Million
CN¥60.28 Million
≈ $8.82 Million
0.078x -13.88%
2011-12-31 CN¥766.17 Million
≈ $112.11 Million
CN¥69.41 Million
≈ $10.16 Million
0.091x -51.30%
2010-12-31 CN¥320.13 Million
≈ $46.84 Million
CN¥59.55 Million
≈ $8.71 Million
0.186x -57.79%
2009-12-31 CN¥307.17 Million
≈ $44.95 Million
CN¥135.38 Million
≈ $19.81 Million
0.441x +345.67%
2008-12-31 CN¥303.19 Million
≈ $44.37 Million
CN¥29.98 Million
≈ $4.39 Million
0.099x +133.82%
2007-12-31 CN¥299.61 Million
≈ $43.84 Million
CN¥-87.60 Million
≈ $-12.82 Million
-0.292x -5856.81%
2006-12-31 CN¥294.62 Million
≈ $43.11 Million
CN¥-1.45 Million
≈ $-211.60K
-0.005x -102.30%
2005-12-31 CN¥289.64 Million
≈ $42.38 Million
CN¥61.82 Million
≈ $9.05 Million
0.213x +842.74%
2004-12-31 CN¥284.03 Million
≈ $41.56 Million
CN¥6.43 Million
≈ $940.95K
0.023x -95.66%
2003-12-31 CN¥88.44 Million
≈ $12.94 Million
CN¥46.18 Million
≈ $6.76 Million
0.522x -27.68%
2002-12-31 CN¥63.02 Million
≈ $9.22 Million
CN¥45.50 Million
≈ $6.66 Million
0.722x --

About Zhejiang Jingxin Pharmaceutical Co Ltd

SHE:002020 China Drug Manufacturers - Specialty & Generic
Market Cap
$1.58 Billion
CN¥10.80 Billion CNY
Market Cap Rank
#7105 Global
#1611 in China
Share Price
CN¥12.54
Change (1 day)
+0.88%
52-Week Range
CN¥11.94 - CN¥21.63
All Time High
CN¥25.17
About

Zhejiang Jingxin Pharmaceutical Co., Ltd. researches and develops, produces, and sells pharmaceutical products and medical devices in China and internationally. The company offers antihypertensive, antibiotics, quinolones, gastrointestinal promotion, antidiabetic, antiepileptic, antihistamine, H+ pump depressant, antihyper cholesterolemia, histamine H2 receptor blockader, antihyper cholesterolemi… Read more